Registrational clinical trial are faster and cheaper than Ph2, they might have enough fund if they don't do the other clinical trials (unlikely though) with the fund from the warrant and 2024 R&D rebate for 3-4 quarters before meaningful data to do another CR. Touch and go if IMU have enough fund for end of 2025 without the fund from the warrant, these have to be exercise to give them enough fund until start of 2026 when they receive around $20M from the 2024 R&D rebate and this will give them funding to middle of 2026 with the warrant.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.2¢ | $267.3K | 20.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 788815 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 13241534 | 29 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |